Trexquant Investment LP Bio Techne Corp Transaction History

Trexquant Investment LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$62.12 - $84.15 $9.6 Million - $13 Million	154,591 New	154,591 $11.1 Million
Q3 2023 Nov 13, 2023	BUY	$67.52 - $89.42 $242,329 - $320,928	3,589 New	3,589 $244,000
Q3 2022 Nov 14, 2022	BUY	$282.54 - $391.85 $1.29 Million - $1.79 Million	4,561 Added 165.79%	7,312 $2.08 Million
Q2 2022 Aug 11, 2022	BUY	$322.67 - $449.65 $887,665 - $1.24 Million	2,751 New	2,751 $954,000
Q1 2022 May 13, 2022	SELL	$353.85 - $487.79 $574,652 - $792,170	-1,624 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$456.15 - $525.06 $740,787 - $852,697	1,624 New	1,624 $840,000
Q2 2020 Aug 07, 2020	SELL	$185.43 - $279.56 $609,137 - $918,354	-3,285 Closed	0 $0
Q1 2020 May 08, 2020	BUY	$161.17 - $221.51 $529,443 - $727,660	3,285 New	3,285 $623,000
Q4 2019 Feb 12, 2020	SELL	$189.68 - $222.09 $349,390 - $409,089	-1,842 Closed	0 $0
Q3 2019 Nov 08, 2019	SELL	$183.56 - $216.72 $253,129 - $298,856	-1,379 Reduced 42.81%	1,842 $360,000
Q2 2019 Aug 09, 2019	BUY	$188.72 - $215.43 $607,867 - $693,900	3,221 New	3,221 $672,000

602

151M

195K

53.2K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.94B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.